Monarch Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,963
Closed -$269K 119
2022
Q2
$269K Sell
7,963
-715
-8% -$25K 0.08% 105
2022
Q1
$303K Sell
8,678
-1,432
-14% -$49K 0.08% 104
2021
Q4
$308K Sell
10,110
-2,349
-19% -$76.5K 0.08% 102
2021
Q3
$409K Sell
12,459
-1,386
-10% -$44.3K 0.11% 92
2021
Q2
$419K Buy
+13,845
New +$456K 0.12% 93

Other funds holding OGN

Monarch Capital Management's OGN Position: Q3 2022 in Review

Monarch Capital Management sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 7,963 shares — an estimated $269K sold.

Monarch Capital Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $419K in Q2 2021. 792 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Monarch Capital Management reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Monarch Capital Management sold 7,963 Organon & Co shares in Q3 2022, an estimated $269K.
  • Monarch Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Monarch Capital Management's Organon & Co position peaked at $419K in Q2 2021.
  • 792 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Monarch Capital Management's 13F filing for Q3 2022, filed 20 Oct 2022.